Effectiveness of a commercial symbiotic in an experimental model of ulcerative colitis
International Journal of Development Research
Effectiveness of a commercial symbiotic in an experimental model of ulcerative colitis
Received 25th October, 2017; Received in revised form 06th November, 2017; Accepted 07th December, 2017; Published online 31st January, 2018
Copyright © 2018, Lidiani Figueiredo Santana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
To verify the effects of a commercial symbiotic in an experimental model of ulcerative colitis. For this, male Wistar rats (5 weeks old) were used. The induction of Ulcerative Colitis was performed via intracolonic route with trinitrobenzenesulfonic acid (TNBS) (10mg TNBS/0.75ml ethanol/50%). The animals were distributed in: sham, treated with ultrapure water (CT); colitis, treated with ultrapure water (TNBS CT); colitis, treated with mesalazine (TNBS MES); and colitis, treated with the symbiotic (TNBS SYM). The following were evaluated: weight, food intake, and the food efficiency coefficient (FEC). After 7 days, euthanasia was performed by removing tissue from the colon for macroscopic and microscopic analysis. After treatment, the TNBS SYM group presented similar body weight to the CT group, but with lower food intake (p<0.001), as well as lower FEC. In the macroscopic analysis, the TNBS SYM group presented lower signs of inflammation and extension of the ulcerations, however without statistical difference in the microscopic analysis. It was observed that under the experimental conditions of the study, the use of the symbiotic maintained body weight and macroscopically reduced the extent of ulceration and tissue aggression, with similar effect to drug use, however, without statistical difference in the microscopic evaluation.